← All trials
NCT01028326
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2010
- Primary completion
- Sep 1, 2010
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 600
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Wellcome TrustLead sponsor
- University of Colorado, DenverCollaborator
- GlaxoSmithKlineCollaborator
- Kenya Ministry of HealthCollaborator
- University of OxfordOverall official - principal investigator
- University of OxfordCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.